ArticlePloS one2013

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway.

Da-Liang Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.